Home > Insider Trading > Filing (0001698450-17-000011)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1433642	Hamilton Lane Inc	HLNE	Investment Advice (6282)	262482738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1698040	Juan Delgado-Moreira	C/O Hamilton Lane Incorporated One Presidential Blvd., 4Th Floor Bala Cynwyd PA 19004	Managing Director	No	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2017-03-06	1,550,965	$0.00	1,550,965	No	4	J	Direct
Class A Common Stock	Acquisiton	2017-03-06	2,800	$16.00	1,553,765	No	4	P	Direct
Restricted Class A Common Stock	Acquisiton	2017-03-06	77,868	$0.00	1,628,833	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	J	Direct
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Employee Stock Option (right to buy)	Acquisiton	2017-03-06	233,495	$0.00	233,495	$1.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
233,495	2017-03-06	2017-06-01	No	4	J	Direct

Footnotes

In the reorganization (the "Reorganization") of Hamilton Lane Advisors, L.L.C. ("HLA") in connection with the Issuer's initial public offering (the "IPO"), the reporting person exchanged membership interests of HLA owned prior to the IPO for Class A Common Stock of the Issuer.
Purchase of shares in Issuer's directed share program in connection with its initial public offering.
Represents the number of shares issued to the reporting person pursuant to an award of restricted stock under the Issuer's 2017 Equity Incentive Plan. The award was issued in substitution for existing awards of restricted interests in HLA that were issued annually in the years prior to the IPO, and the new award vests according to the same vesting schedule as the replaced awards: in four equal annual installments each March. Accordingly, one tranche will vest in 2017, one in 2018, one in 2019 and one in 2020.
These options were granted under the Issuer's 2017 Equity Incentive Plan in substitution for outstanding options to purchase non-voting interests of HLA that were issued in 2007, prior to the IPO. The options being replaced were fully vested, and so the substitute award is fully vested.